CXCL13 抗体 (AA 23-109)
(5 references)Our Local Distributor
北京 101111
Quick Overview for CXCL13 抗体 (AA 23-109) (ABIN741960)
抗原
See all CXCL13 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 23-109
-
交叉反应
- 人, 小鼠
-
预测反应
- Dog
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human CXCL13
-
亚型
- IgG
-
-
anti-Chemokine (C-X-C Motif) Ligand 13 (CXCL13) (AA 23-109) antibody
CXCL13 适用: 小鼠, 大鼠 WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Chemokine (C-X-C Motif) Ligand 13 (CXCL13) (AA 22-108) antibodyCXCL13 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Chemokine (C-X-C Motif) Ligand 13 (CXCL13) (AA 1-109) antibodyCXCL13 适用: 人 WB, IP 宿主: 兔 Polyclonal unconjugated
anti-Chemokine (C-X-C Motif) Ligand 13 (CXCL13) (AA 22-109) antibodyCXCL13 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Chemokine (C-X-C Motif) Ligand 13 (CXCL13) (AA 23-95) antibodyCXCL13 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Chemokine (C-X-C Motif) Ligand 13 (CXCL13) (AA 1-109) antibodyCXCL13 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Chemokine (C-X-C Motif) Ligand 13 (CXCL13) (AA 22-109) antibodyCXCL13 适用: 小鼠 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Chemokine (C-X-C Motif) Ligand 13 (CXCL13) (AA 22-109) antibodyCXCL13 适用: 小鼠 WB, IHC, IP, IF/ICC 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
-
: "Up-regulation of chemokine CXCL13 in systemic candidiasis." in: Clinical immunology (Orlando, Fla.), (2018) (PubMed).
: "Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study." in: European journal of haematology, (2015) (PubMed).
: "Orosomucoid 1 drives opportunistic infections through the polarization of monocytes to the M2b phenotype." in: Cytokine, Vol. 73, Issue 1, pp. 8-15, (2015) (PubMed).
: "Renal interstitial infiltration and tertiary lymphoid organ neogenesis in IgA nephropathy." in: Clinical journal of the American Society of Nephrology : CJASN, Vol. 9, Issue 2, pp. 255-64, (2014) (PubMed).
: "IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media." in: Immunology and cell biology, (2014) (PubMed).
-
: "Up-regulation of chemokine CXCL13 in systemic candidiasis." in: Clinical immunology (Orlando, Fla.), (2018) (PubMed).
-
- CXCL13 (Chemokine (C-X-C Motif) Ligand 13 (CXCL13))
-
别名
- CXCL13/BCA1
-
背景
-
Synonyms: BLC, BCA1, ANGIE, BCA-1, BLR1L, ANGIE2, SCYB13, C-X-C motif chemokine 13, B cell-attracting chemokine 1, B lymphocyte chemoattractant, CXC chemokine BLC, Small-inducible cytokine B13, CXCL13
Background: Chemotactic for B-lymphocytes but not for T-lymphocytes, monocytes and neutrophils. Does not induce calcium release in B-lymphocytes. Binds to BLR1/CXCR5.
-
基因ID
- 10563
-
UniProt
- O43927
抗原
-
